Treatment-modifications to CI speech processor program for To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Washington University School of Medicine, Saint Louis, MO
To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
Treatment-modifications to CI speech processor program - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Interaural loudness and pitch mismatch in SSD-CI recipients reduces binaural processing cues and contributes to performance outcomes, specifically speech understanding in noise and localization. We aim to improve binaural cues through speech processor program modifications that reduce interaural mismatches.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
Speech understanding in noise

Trial Safety

Safety Progress

1 of 3

Other trials for To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients

Trial Design

1 Treatment Group

Single arm
1 of 1
Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Treatment-modifications to CI speech processor program · No Placebo Group · N/A

Single arm
Device
Experimental Group · 1 Intervention: Treatment-modifications to CI speech processor program · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: Washington University School of Medicine · Saint Louis, MO
Photo of washington university school of medicine 1Photo of washington university school of medicine 2Photo of washington university school of medicine 3
2004First Recorded Clinical Trial
1 TrialsResearching To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
1474 CompletedClinical Trials

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,772 Previous Clinical Trials
2,270,631 Total Patients Enrolled
CochlearIndustry Sponsor
77 Previous Clinical Trials
5,670 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a hearing loss in your better ear that is at least 30 dB HL in the contralateral ear.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.